Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl L Roland

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy|May 12, 2006
Partners for understanding pain: resources and toolkits to increase public awarenessCarl L Roland
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Postgraduate Medicine|December 15, 2016
Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposureCarl L Roland, Beatrice Setnik, David A Brown
Journal of Pain & Palliative Care Pharmacotherapy|November 2, 2016
Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic ReviewCarl L Roland, Joanita Lake, Gary M Oderda
Substance Abuse and Rehabilitation|July 16, 2016
Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adultsScott P Novak, Cristie Glasheen, Carl L Roland
Journal of Clinical Pharmacology|July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog ScalesBeatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Pain Medicine (Malden, Mass.)|April 6, 2011
The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodoneBeatrice Setnik, Carl L Roland, Jody M Cleveland, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2018
The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and PoisoningCarl L Roland, Xiangyang Ye, Vanessa Stevens, et al.
Postgraduate Medicine|June 18, 2011
Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodoneCarl L Roland, Beatrice Setnik, Jody M Cleveland, et al.
Journal of Opioid Management|May 28, 2013
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patientsBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Pain & Palliative Care Pharmacotherapy|May 12, 2006
Partners for understanding pain: resources and toolkits to increase public awarenessCarl L Roland
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Postgraduate Medicine|December 15, 2016
Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposureCarl L Roland, Beatrice Setnik, David A Brown
Journal of Pain & Palliative Care Pharmacotherapy|November 2, 2016
Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic ReviewCarl L Roland, Joanita Lake, Gary M Oderda
Substance Abuse and Rehabilitation|July 16, 2016
Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adultsScott P Novak, Cristie Glasheen, Carl L Roland
Journal of Clinical Pharmacology|July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog ScalesBeatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Pain Medicine (Malden, Mass.)|April 6, 2011
The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodoneBeatrice Setnik, Carl L Roland, Jody M Cleveland, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2018
The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and PoisoningCarl L Roland, Xiangyang Ye, Vanessa Stevens, et al.
Postgraduate Medicine|June 18, 2011
Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodoneCarl L Roland, Beatrice Setnik, Jody M Cleveland, et al.
Journal of Opioid Management|May 28, 2013
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patientsBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Pageof 4